Sovran Advisors, LLC Abb Vie Inc. Transaction History
Sovran Advisors, LLC
- $770 Billion
- Q1 2025
A detailed history of Sovran Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sovran Advisors, LLC holds 3,519 shares of ABBV stock, worth $680,961. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,519
Previous 3,144
11.93%
Holding current value
$680,961
Previous $552 Million
10.3%
% of portfolio
0.08%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,169Shares Held
1.29BCall Options Held
17MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$33.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.68 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $342B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...